|EPGNF -- USA Stock|| |
USD 2.68 0.0029 0.11%
Mr. Heino von Prondzynski is Chairman of the Supervisory Board of Epigenomics AG since May 2, 2012. He was Member of the Supervisory Board at Epigenomics AG from May 29, 2007 until March 31, 2010. Until December 2005, he headed the Diagnostics Division at F.HoffmannLa Roche AG, Basel. Before that, he held senior positions in the Vaccine business at Chiron Corporationration in Germany, Italy and the Unted States and in the Pharma, Selfmedication and Diagnostic business at Bayer AG in Germany, Austria and Brazil. After retiring from his position as Chief Executive Officer of the Roche Diagnostics division, Mr. von Prondzynski works as Independent Consultant. He serves at the Supervisory Boards of Koninklijke Philips Electronics NV, Qiagen NV and Hospira Inc., among others.
Age: 67 Chairman Since 2012
49 30 243 450 http://www.epigenomics.com
von Prondzynski studied mathematics, geography, and history at the Westfaelische WilhelmsUniversitaet, Muenster, Germany.